Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 36.4% in March

Nyxoah S.A. (NASDAQ:NYXH) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 63,700 shares, a decline of 36.4% from the February 28th total of 100,200 shares. Based on an average daily volume of 47,400 shares, the short-interest ratio is currently 1.3 days. Currently, 0.4% of the company’s shares are sold short.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. HC Wainwright cut their price target on Nyxoah from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday. Stifel Nicolaus reduced their price target on shares of Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, March 14th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Kovack Advisors Inc. lifted its stake in Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock valued at $160,000 after purchasing an additional 10,000 shares during the last quarter. LPL Financial LLC purchased a new position in shares of Nyxoah during the 4th quarter valued at $102,000. Geode Capital Management LLC lifted its position in shares of Nyxoah by 19.4% during the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after buying an additional 2,774 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in Nyxoah in the 4th quarter worth about $187,000. Finally, Walleye Capital LLC raised its stake in Nyxoah by 23.9% in the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock valued at $119,000 after acquiring an additional 2,862 shares during the period.

Nyxoah Stock Performance

Shares of NYXH traded down $0.35 on Friday, reaching $7.65. 81,348 shares of the company’s stock traded hands, compared to its average volume of 46,675. The stock’s 50 day simple moving average is $10.35 and its two-hundred day simple moving average is $9.34. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. Nyxoah has a 52-week low of $6.76 and a 52-week high of $13.50. The stock has a market cap of $260.56 million, a PE ratio of -4.09 and a beta of 1.42.

Nyxoah (NASDAQ:NYXH) last released its earnings results on Thursday, March 13th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The business had revenue of $1.35 million for the quarter, compared to the consensus estimate of $2.02 million. Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%. On average, analysts forecast that Nyxoah will post -1.91 earnings per share for the current fiscal year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.